Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 77771-451
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 77771-451). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Radha Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Atorvastatin-10mg-90tab (Atorvastatin 10mg 90tab)
This is a description for Atorvastatin Calcium tablets. Each film-coated tablet contains 10 mg of atorvastatin. The usual dosage and storage instructions can be found in the accompanying prescribing information. The medication should be kept in a tight, child-resistant container and it is important to keep it out of the reach of children. The tablets are manufactured by Scieben Pharmaceuticals, Inc. and distributed by Radha Pharmaceuticals, Inc. The NDC (National Drug Code) is 77771-451-90.*
Atorvastatin-20mg-500tab (Atorvastatin 20mg 500tab)
Atorvastatin-20mg-90tab (Atorvastatin 20mg 90tab)
Atorvastatin-40mg-1000tab (Atorvastatin 40mg 1000tab)
Atorvastatin-40mg-90tab (Atorvastatin 40mg 90tab)
Atorvastatin-80mg-500tab (Atorvastatin 80mg 500tab)
Atorvastatin-80mg-90tab (Atorvastatin 80mg 90tab)
Chemical-structure (Chemical Structure)
Figure-01 (Figure 1)
This text appears to be displaying statistical information about a cumulative incidence rate. The numbers 40, 15, 20, 25, 30, and 35 might be representing different time points or intervals in years. The text mentions a hazard ratio (HR) of 0.64 with a corresponding confidence interval (0.50-0.83) and a p-value of 0.0005. Without further context, it is difficult to determine the specific meaning or context of the presented data.*
Figure-02 (Figure 2)
This text provides information on the Cumulative Hazard (%) and the comparison between Placebo and Atorvastatin. The Hazard Ratio (HR) for Atorvastatin compared to Placebo is 0.63, with a 95% confidence interval of 0.48-0.83, and a p-value of 0.001. The graph shows the time to the first primary endpoint over a follow-up period of four years.*
Figure-03 (Figure 3)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.